glp-1 for heart health The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action FDA Approves First Oral GLP-1

We have no clue how you'll respond or whether it's safe." To lose a small amount of weight Influencers often tout microdosing as a way to lose "those last 10 pounds," despite the fact that GLP-1 drugs are approved for people with obesity or those who are overweight and have related health conditions

Busko M

10.1371/journal.pone.0069010 16 Eren-YaziciogluC

The clinical results are well-documented

King Law Is Investigating Ozempic Claims Related to Severe Side Effects Allegedly Caused by Ozempic Our Ozempic Legal Team at King Law Contact an Ozempic Lawyer Today Key Takeaways Heres some key information about the Ozempic lawsuits: There are more than 3,700 claims across two MDLs filed since the litigation began in 2024 (the MDLs also include lawsuits for those injured by Wegovy, Mounjaro, and other GLP-1 drugs) Key legal claims against Novo Nordisk include failure to warn, negligence, negligent marketing, and product liability (for a pharmaceutical drug) Defendants are Novo Nordisk and Eli Lilly (which makes other GLP-1 drugs) There are two MDLs for the Ozempic injury claims: Number of pending claims in MDL 3094 as of July 1, 2026: 3,848 Number of pending claims in MDL 3163 as of July 1, 2026: 146 People can file individual Ozempic lawsuits or join the active MDLs The Honorable Karen S